Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in DHR — Danaher Corp /De/

CIK 886982 NEW YORK, NY
Back to DHR Full portfolio

Position in DHR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$873,921,002
-$228,911,396 QoQ
Shares Held
4,609,288
-4.3% QoQ
Ownership
0.651%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 81.22072215925756.ToString("F0")% Shared 0.6130447912996541.ToString("F0")% None 18.166233049442777.ToString("F0")%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Derivatives in DHR

reported options exposure · as of Mar 31, 2026
CallValue
$6,162,000
CallShares
32,500
PutValue
$6,863,520
PutShares
36,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $5,861,764,434 across 35 Diagnostics & Research names. DHR ranks #2 (14.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 3,157,226 $1,551,871,293
2 DHR
Danaher Corp /De/
This page 		4,609,288 $873,921,002
3 MTD
Mettler Toledo International Inc/
 387,844 $489,148,850
4 GH
Guardant Health, Inc.
 4,435,839 $409,738,446
5 A
Agilent Technologies, Inc.
 3,577,648 $407,780,316
6 IDXX
Idexx Laboratories Inc /De
 716,921 $402,830,739
7 DGX
Quest Diagnostics Inc
 1,348,694 $264,317,047
8 IQV
Iqvia Holdings Inc.
 1,177,280 $200,773,329

All Filings in DHR

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $873,921,002 4,609,288
2026-03-31 $6,863,520 36,200
2026-03-31 $6,162,000 32,500
2025-12-31 $10,232,724 44,700
2025-12-31 $1,102,832,398 4,817,545
2025-09-30 $6,661,536 33,600
2025-09-30 $893,861,552 4,508,532
2025-06-30 $1,064,630,962 5,389,445
2025-06-30 $5,412,596 27,400
2025-06-30 $434,588 2,200
2025-03-31 $1,373,500 6,700
2025-03-31 $8,856,000 43,200
2025-03-31 $986,242,290 4,810,938
2024-12-31 $1,227,524,130 5,347,524
2024-12-31 $14,002,550 61,000
2024-12-31 $6,289,670 27,400
2024-09-30 $19,044,370 68,500
2024-09-30 $7,617,748 27,400
2024-09-30 $1,602,156,138 5,762,737
2024-06-30 $1,517,411,254 6,073,289
2024-06-30 $1,574,055 6,300
2024-06-30 $11,842,890 47,400
2024-03-31 $3,570,996 14,300
2024-03-31 $13,834,488 55,400
2024-03-31 $1,398,278,670 5,599,386
2023-12-31 $5,182,016 22,400
2023-12-31 $15,522,914 67,100
2023-12-31 $1,213,578,173 5,245,864
2023-09-30 $1,163,013,132 5,287,702
2023-09-30 $4,464,920 20,300
2023-09-30 $14,296,542 65,000
2023-06-30 $13,829,790 65,000
2023-06-30 $563,269,897 2,647,368
2023-03-31 $1,541,733 6,900
2023-03-31 $821,485,885 3,676,544
2023-03-31 $1,474,702 6,600
2022-12-31 $799,927,812 3,399,588
2022-12-31 $13,553,360 57,600
2022-12-31 $12,118,022 51,500
2022-09-30 $900,329,571 3,931,905
2022-09-30 $18,593,216 81,200
2022-09-30 $17,196,435 75,100
2022-06-30 $8,563,043 38,100
2022-06-30 $8,563,043 38,100
2022-06-30 $784,627,410 3,491,084
2022-03-31 $11,701,993 45,000
2022-03-31 $12,222,082 47,000
2022-03-31 $812,636,094 3,124,991
2021-12-31 $20,417,285 70,000
2021-12-31 $867,332,387 2,973,621

Report a Problem

Category
Description
Email (optional, for follow-up)